Cargando…
Dynamically modeling the effective range of IL-2 dosage in the treatment of systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease characterized by an overactive immune response to self-antigen. The overactivation of CD4(+) Foxp3(−) conventional T cells (Tcons) and the inactivation of CD4(+) CD25(+) Foxp3(+) regulatory T cells (Tregs) play important rol...
Autores principales: | Gao, Xin, He, Jing, Sun, Xiaolin, Li, Fangting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429801/ https://www.ncbi.nlm.nih.gov/pubmed/36060072 http://dx.doi.org/10.1016/j.isci.2022.104911 |
Ejemplares similares
-
IL-17 in Systemic Lupus Erythematosus
por: Crispín, José C., et al.
Publicado: (2010) -
IL-10 revisited in systemic lupus erythematosus
por: Biswas, Swayanka, et al.
Publicado: (2022) -
An era of biological treatment in systemic lupus erythematosus
por: He, Jing, et al.
Publicado: (2017) -
Anti-IL-10 antibody in systemic lupus erythematosus
por: Uchida, Marina, et al.
Publicado: (2019) -
Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus
por: Godsell, Jack, et al.
Publicado: (2016)